Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 1,172,875 | 872,423 | 585,979 | 272,277 | 173,781 |
| Cost of Goods | 117,418 | 102,146 | 78,425 | 13,942 | 13,559 |
| Gross Profit | 1,055,457 | 770,277 | 507,554 | 258,335 | 160,222 |
| Operating Expenses | 860,288 | 430,111 | 310,135 | 131,446 | 102,992 |
| Operating Income | 195,587 | 340,312 | 197,844 | 127,831 | 57,789 |
| Interest Expense | 52,713 | 26,916 | 16,869 | 1,600 | 12,724 |
| Other Income | 8,683 | -5,446 | -3,620 | -1,247 | -12,287 |
| Pre-tax Income | 151,557 | 307,950 | 177,355 | 124,984 | 32,778 |
| Income Tax | 94,231 | 91,638 | -83,794 | 0 | 0 |
| Net Income Continuous | 57,326 | 216,312 | 261,149 | 124,984 | 32,778 |
| Net Income Discontinuous | N/A | N/A | 27,437 | 0 | 0 |
| Minority Interests | -1,061 | 0 | 0 | N/A | N/A |
| Net Income | $58,387 | $216,312 | $288,586 | $124,984 | $32,778 |
| EPS Basic Total Ops | 0.98 | 3.71 | 5.09 | 3.01 | 0.90 |
| EPS Basic Continuous Ops | 0.96 | 3.71 | 4.61 | 3.01 | 0.90 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.48 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.93 | 3.51 | 4.79 | 2.67 | 0.83 |
| EPS Diluted Continuous Ops | 0.92 | 3.51 | 4.34 | 2.67 | 0.83 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.45 | 0.00 | 0.00 |
| EBITDA(a) | $342,993 | $426,993 | $272,073 | $135,658 | $66,500 |